KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
132 hedge funds and large institutions have $278M invested in Keryx Biopharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
11% less capital invested
Capital invested by funds: $313M → $278M (-$35.3M)
Holders
132
Holding in Top 10
–
Calls
$2.21M
Puts
$2.22M
Top Buyers
| 1 | +$5.53M | |
| 2 | +$2.9M | |
| 3 | +$2.01M | |
| 4 |
OWIM
Old West Investment Management
Los Angeles,
California
|
+$1.67M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.36M |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$3.81M | |
| 3 | -$3.05M | |
| 4 |
Goldman Sachs
New York
|
-$2.72M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$1.24M |